Boston Scientific Corporation

Key Statistics

Recent News

• Boston Scientific Eyes Neurovascular Growth With Penumbra Thunderbolt Clearance Simply Wall St.

  Penumbra received FDA clearance for its Thunderbolt stroke thrombectomy device. Boston Scientific (NYSE:BSX) previously agreed to acquire Penumbra, with closing expected later this year. The clearance

• Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months Motley Fool

  Analysts remain relatively more upbeat, but this could prove fleeting.

• FDA clears Penumbra’s Thunderbolt thrombectomy platform for stroke Medical Device Network

  Penumbra’s computer assisted vacuum thrombectomy platform uses aspiration for clot removal during acute ischemic stroke treatment.

• Penumbra’s FDA nod for clot removal tech a win for Boston Scientific MedTech Dive

  The stroke treatment could contribute about $100 million in incremental revenue over time to Boston Scientific, the buyer of Penumbra, one analyst said.

• Elfun Trusts Exits Abbott Laboratories, Impacting Portfolio by -1.97% GuruFocus.com

  Insightful Moves in Elfun Trusts (Trades, Portfolio)' First Quarter 2026 N-PORT Filing

• BTIG Remains Bullish On Boston Scientific (BSX); Check Out What It Says About The Stock Insider Monkey

  With a forward P/E of 14.45x and upside potential of 59.60%, Boston Scientific Corporation (NYSE:BSX) ranks among the top 10 lowest forward P/E stocks in the S&P 500. Boston Scientific Corporation (NY

• Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know Zacks

  Boston Scientific (BSX) concluded the recent trading session at $48.34, signifying a -1.27% move from its prior day's close.

• Is Boston Scientific (BSX) One of the Best Healthcare Stocks to Buy With the Highest Upside Potential? Insider Monkey

  Boston Scientific Corporation (NYSE:BSX) is one of the best healthcare stocks to buy with highest upside potential. TD Cowen cut the price target on Boston Scientific Corporation (NYSE:BSX) to $61 fro